Abstract: A fault detection method, includes the following steps. A target sequence is received, the target sequence includes several data. A first moving average operation is performed on the target sequence to establish a first moving average sequence. A second moving average operation is performed on the target sequence to establish a second moving average sequence. A difference operation between the first moving average sequence and the second moving average sequence is performed to obtain a difference sequence, the difference sequence includes several difference values. An upper limit value is set. When one of the difference values is greater than the upper limit value, the target sequence is determines as abnormal.

Abstract: A display panel including a circuit board, a plurality of bonding pads, a plurality of light emitting devices, and a plurality of solder patterns is provided. The bonding pads are disposed on the circuit board, and each includes a first metal layer and a second metal layer. The second metal layer is located between the first metal layer and the circuit board. The first metal layer includes an opening overlapping the second metal layer. A material of the first metal layer is different from a material of the second metal layer. The light emitting devices are electrically bonded to the bonding pads. Each of the solder patterns electrically connects one of the light emitting devices and one of the bonding pads. The solder patterns each contact the second metal layer through the opening of the first metal layer of one of the bonding pads to form a eutectic bonding.

Abstract: The present invention provides a method for treating cancer, the method including the step of: administering a therapeutically effective concentration of chlorophyllide to a subject in need thereof. The present invention further provides a method for treating cancer, the method including the step of: administering a composition to a subject in need thereof, wherein the composition includes: a therapeutically effective concentration of chlorophyllide and a therapeutically effective concentration of anthracycline.

Abstract: The present invention provides a method for treating or preventing virus infection, the method including the step of: administering a therapeutically effective concentration of chlorophyllide to a subject in need thereof. The present invention further provides a method for treating or preventing virus infection, the method including the step of: administering a product obtained by treating a plant leaf extract with chlorophyllase to a subject in need thereof, wherein the product comprises a therapeutically effective concentration of chlorophyllide.

Abstract: The present invention discloses a three-dimensional cell spheroid with high proliferation activity, and the cell spheroid is obtained by ejecting a cell aggregate through a needle with a needle gauge of less than 30G. The present invention further provides the producing method and the use for the cell spheroid.

Abstract: A medium for culturing Antrodia cinnamomea includes a carbon source, a nitrogen source, vitamin A, agar and a solvent. The medium includes 8-16 grams/liter of the carbon source, 0.4-1.6 grams/liter of the nitrogen source and 4 grams/liter of vitamin A. Moreover, a method for culturing Antrodia cinnamomea includes inoculating the medium with mycelia of Antrodia cinnamomea. The mycelia of Antrodia cinnamomea inoculated on the medium is cultured at 20-27° C. for 28-50 days.

Abstract: Disclosed herein is that an active ingredient obtained from cultivation of Cordyceps militaris can be used in the treatment of glioblastoma.

Abstract: A method for preparing a hemisphere-shaped dosage form containing drug. A high molecular weight solution containing the drug is prepared, and the solution is then dropped onto a base material. The interface phenomenon between the solution and different base materials causes the solution to form a hemisphere-shaped liquid drop dosage. After solidifying by cross-link or evaporation, a hemisphere-shaped dosage form containing drug is obtained. The advantages of the preparation method are a simple and fast process, and simple operation. Applications of the preparation method to prepare a hemisphere-shaped dosage form containing drug are also provide.

Abstract: An electrospinning manufacture for drug carriers is disclosed. The method comprises a preliminary step mixing a predetermined drug, an alginate, and a saline to obtain a mixture; an electric field establishing step providing a collection plate and an emitter filled with divalent cation agent and the mixture individually, wherein an electric field is applied to the collection plate and the emitter to form a voltage therebetween; and an electrospinning step sequentially dropping the mixture from the emitter into the divalent cation agent filled in the collection plate via the driving of the electric field, triggering a crosslinking-gelating reaction between the divalent cation and the alginate, wherein a plurality of gel particles is produced for a coating of the predetermined drug presenting a drug carrier performance.

Abstract: An electrospinning manufacture for drug carriers is disclosed. The method comprises a preliminary step mixing a predetermined drug, an alginate, and a saline to obtain a mixture; an electric field establishing step providing a collection plate and an emitter filled with divalent cation agent and the mixture individually, wherein an electric field is applied to the collection plate and the emitter to form a voltage therebetween; and an electrospinning step sequentially dropping the mixture from the emitter into the divalent cation agent filled in the collection plate via the driving of the electric field, triggering a crosslinking-gelating reaction between the divalent cation and the alginate, wherein a plurality of gel particles is produced for a coating of the predetermined drug presenting a drug carrier performance.

Abstract: A drug carrier for treating of gastrointestinal ulcer comprises a microspheroid having a substrate and a plurality of particles distributed over and covered by the substrate, wherein the substrate is alginate and the plurality of particles is a drug for treating of gastrointestinal ulcer; and a coat covering up the surface of the microspheroid, which contains chitosan.

Abstract: A drug carrier comprises a substance, a paramagnetic particle, a rod-shaped light-absorbing particle and a drug. The paramagnetic particle, the drug and the rod-shaped light-absorbing particle absorbing light and generating heat are provided in the substance.

Abstract: A formula of medium for culturing Cordyceps spp. comprises 1˜6 wt % of carbon sources, 0.8˜51.5 wt % of nitrogen sources, 2˜12 wt % of alginate and 86.2˜95.2 wt % of solvent.

Abstract: A temperature-adjustable biochip assembly has a biochip with a microfluidic channel embedded inside and a temperature-controlling unit including a substance sited at a surface of the biochip, a cyclic guiding module passing through the substance, and a fluid flowed inside the cyclic guiding module, with the cyclic guiding module having a fluidic installed in the substance for guiding the fluid and a temperature-controlling component for modulating the temperature of fluid.

Abstract: A method for preparing drug in hemisphere-shaped dosage form. A high molecular weight solution containing the drug is prepared, and the solution is then dropped on a base material. The interface phenomena between the solution and different base materials makes the drop of high molecular weight solution containing the drug form a hemisphere-shape. After solidifying by cross-link or evaporation, the drug in hemisphere-shaped dosage form is obtained. The advantages of the preparation method are a simple and fast process, and simple operation. Applications of the method to prepare a drug in hemisphere-shaped dosage form are also provided.